Literature DB >> 30735755

Strategies for the measurements of expression levels and half-lives of HLA class I allotypes.

Malini Raghavan1, Brogan Yarzabek2, Anita J Zaitouna2, Sujatha Krishnakumar3, Daniel S Ramon4.   

Abstract

HLA class I molecules are highly polymorphic cell surface proteins that trigger immune responses by CD8+ T cells and natural killer (NK) cells. Most humans express six different HLA class I proteins encoded by the HLA-A, HLA-B and HLA-C genes. HLA class I molecules bind to peptide antigens and present these antigens to T cell receptors (TCR) of CD8+ T cells. HLA class I expression levels also regulate NK cell activation. The presence of individual HLA class I genes is linked to many different disease, transplantation and therapy outcomes. An understanding of HLA class I expression and stability patterns is fundamentally important towards a better understanding of the associations of HLA class I genes with disease and treatment outcomes, and towards HLA class I targeting for vaccine development. Quantitative flow cytometry allows for assessments of variations in expression levels of HLA class I molecules in cells from a single blood donor over time, as well as averaged measurements across donors for the same allotype. Since all HLA class I molecules are structurally-related, cellular measurements of the HLA class I expression levels and stabilities of individual variants in human cells require careful choices of donors and antibodies, which are discussed here.
Copyright © 2019 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  HLA class I; HLA-B; Half-life; Luminex assay; Next-generation sequencing; Quantitative flow cytometry; Stability

Mesh:

Substances:

Year:  2019        PMID: 30735755      PMCID: PMC6662657          DOI: 10.1016/j.humimm.2019.02.001

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  40 in total

1.  Optimization of the MHC class I peptide cargo is dependent on tapasin.

Authors:  Anthony P Williams; Chen Au Peh; Anthony W Purcell; James McCluskey; Tim Elliott
Journal:  Immunity       Date:  2002-04       Impact factor: 31.745

Review 2.  Structure, function, and diversity of class I major histocompatibility complex molecules.

Authors:  P J Bjorkman; P Parham
Journal:  Annu Rev Biochem       Date:  1990       Impact factor: 23.643

Review 3.  HIV and HLA class I: an evolving relationship.

Authors:  Philip J R Goulder; Bruce D Walker
Journal:  Immunity       Date:  2012-09-21       Impact factor: 31.745

Review 4.  Immunogenetics of spontaneous control of HIV.

Authors:  Mary Carrington; Bruce D Walker
Journal:  Annu Rev Med       Date:  2012       Impact factor: 13.739

Review 5.  Pathways of antigen processing.

Authors:  Janice S Blum; Pamela A Wearsch; Peter Cresswell
Journal:  Annu Rev Immunol       Date:  2013-01-03       Impact factor: 28.527

Review 6.  Species-specific evolution of MHC class I genes in the higher primates.

Authors:  E J Adams; P Parham
Journal:  Immunol Rev       Date:  2001-10       Impact factor: 12.988

7.  HLA-C cell surface expression and control of HIV/AIDS correlate with a variant upstream of HLA-C.

Authors:  Rasmi Thomas; Richard Apps; Ying Qi; Xiaojiang Gao; Victoria Male; Colm O'hUigin; Geraldine O'Connor; Dongliang Ge; Jacques Fellay; Jeffrey N Martin; Joseph Margolick; James J Goedert; Susan Buchbinder; Gregory D Kirk; Maureen P Martin; Amalio Telenti; Steven G Deeks; Bruce D Walker; David Goldstein; Daniel W McVicar; Ashley Moffett; Mary Carrington
Journal:  Nat Genet       Date:  2009-12       Impact factor: 38.330

8.  Tapasin is a facilitator, not an editor, of class I MHC peptide binding.

Authors:  Angela L Zarling; Chance John Luckey; Jarrod A Marto; Forest M White; Cynthia J Brame; Anne M Evans; Paul J Lehner; Peter Cresswell; Jeffrey Shabanowitz; Donald F Hunt; Victor H Engelhard
Journal:  J Immunol       Date:  2003-11-15       Impact factor: 5.422

9.  Differential microRNA regulation of HLA-C expression and its association with HIV control.

Authors:  Smita Kulkarni; Ram Savan; Ying Qi; Xiaojiang Gao; Yuko Yuki; Sara E Bass; Maureen P Martin; Peter Hunt; Steven G Deeks; Amalio Telenti; Florencia Pereyra; David Goldstein; Steven Wolinsky; Bruce Walker; Howard A Young; Mary Carrington
Journal:  Nature       Date:  2011-04-17       Impact factor: 49.962

10.  Natural HLA class I polymorphism controls the pathway of antigen presentation and susceptibility to viral evasion.

Authors:  Danielle Zernich; Anthony W Purcell; Whitney A Macdonald; Lars Kjer-Nielsen; Lauren K Ely; Nihay Laham; Tanya Crockford; Nicole A Mifsud; Mandvi Bharadwaj; Linus Chang; Brian D Tait; Rhonda Holdsworth; Andrew G Brooks; Stephen P Bottomley; Travis Beddoe; Chen Au Peh; Jamie Rossjohn; James McCluskey
Journal:  J Exp Med       Date:  2004-06-28       Impact factor: 14.307

View more
  1 in total

1.  Assessments of HLA-I Specificities of Anti-HLA-I Monoclonal Antibodies Using Solid Phase Bead Arrays.

Authors:  Anita J Zaitouna; Daniel S Ramon; Malini Raghavan
Journal:  Bio Protoc       Date:  2020-06-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.